» Articles » PMID: 29380165

Impact of Cardiovascular Risk Factors on the Achievement of Therapeutic Goals in Psoriatic Arthritis: is There Any Association?

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2018 Jan 31
PMID 29380165
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular risk factors (CVRFs) have been related to poorer responses to systemic therapy in psoriatic arthritis (PsA). We aimed to evaluate the potential association between CVRFs and the achievement of therapeutic goals in PsA patients receiving systemic therapy. A cross-sectional study was carried out at 25 rheumatology outpatient clinics in Spain. PsA patients with established disease who were treated with conventional and biologic systemic therapies were included. The treatment goals measured were minimal disease activity (MDA) and very low disease activity (VLDA) responses. The relationship between MDA/VLDA and CVRFs was evaluated by uni- and multivariate models. Of a total of 227 patients, 133 (58.6%) and 26 (11.5%) patients were in MDA and VLDA, respectively. Tobacco use (crude OR 0.54), sedentary lifestyle (crude OR 1.95), hyperuricemia (crude OR 2.01) and obesity (crude OR 1.54) were related to the likelihood of MDA in the univariate model (p < 0.25), while in multivariate analysis, a sedentary lifestyle (OR 3.13, 95%CI 1.50-6.53; p = 0.002) increased the odds of having reached MDA. Obesity (crude OR 2.2) and dyslipidaemia (crude OR 1.80) were associated with VLDA in univariate analysis, whereas dyslipidaemia (OR 5.3, 95%CI 1.7-16.6; p = 0.004) increased the odds of VLDA in the multivariate model. We found no association between the number of CVRFs and the MDA/VLDA responses. In this cross-sectional, multicentre study, we could not find any relationship between CVRFs and lower odds of achieving stringent therapeutic goals in PsA. In any case, patients with psoriatic disease should be encouraged to maintain healthy lifestyle habits.

Citing Articles

Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes.

Alonso-Castro S, Garcia-Valle A, Morante-Bolado I, Brana I, Pardo E, Queiro R J Clin Med. 2023; 12(2).

PMID: 36675480 PMC: 9865976. DOI: 10.3390/jcm12020551.


Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence.

Coates L, de Wit M, Buchanan-Hughes A, Smulders M, Sheahan A, Ogdie A Rheumatol Ther. 2022; 9(3):803-821.

PMID: 35412298 PMC: 9127027. DOI: 10.1007/s40744-022-00443-y.


A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis.

Queiro R, Charca L, Pino M Arch Med Sci. 2021; 17(2):557-560.

PMID: 33747293 PMC: 7959045. DOI: 10.5114/aoms/132315.


Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study.

Lubrano E, Scriffignano S, Azuaga A, Ramirez J, Canete J, Perrotta F Rheumatol Ther. 2020; 7(4):825-836.

PMID: 32804332 PMC: 7695787. DOI: 10.1007/s40744-020-00229-0.


Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.

Queiro R, Canete J, Montoro M, Gomez S, Cabez A Arthritis Res Ther. 2020; 22(1):82.

PMID: 32295620 PMC: 7161121. DOI: 10.1186/s13075-020-02168-1.